Table 1:

Patient demographics and imaging characteristics

CharacteristicCVF+ (n = 40)CVF– (n = 32)
Mean age (range) (yr)61.6 (SD, 9.2) (34–83)58.2 (SD, 9.6) (22–71)
Sex female (%)/male (%)23 (58%)/17 (42%)23 (72%)/9 (28%)
Bern score
 Median (range; IQR)6 (1–9; 3)a1 (0–6; 2)
 Low probability 0–2 (%)1 (2.5%)28 (87.5%)
 Intermediate probability 3–4 (%)10 (25%)3 (9.4%)
 High probability 5–9 (%)29 (72.5%)1 (3.1%)
WMH
 Mean total WMH (SD)7.9 (8.2)a20.7 (21.8)
 Mean frontal WMH (SD)5.4 (6.5)a14.6 (14.1)
 Median percentage frontal WMH (IQR)53.3 (52.2)70.6 (31.2)
WMH pattern (No.) (%)
 Minimal22 (55%)10 (32.3%)
 Migrainous5 (12.5%)15 (46.9%)
 Microangiopathic13 (32.5%)7 (21.9%)
  • Note:—IQR indicates interquartile range.

  • a Denotes P < .05 after Bonferroni adjustment. Patients with myelographically-proved CVF have higher Bern scores and fewer WMH. There is a strong correlation between the Bern score and CVF positivity (rpb = −0.82).